X0508 4 2026-02-02 false 0001517022 Akebia Therapeutics, Inc. AKBA 0002007730 Malabre Richard C C/O AKEBIA THERAPEUTICS, INC 245 FIRST ST. CAMBRIDGE MA 02142 false true false false SVP, Chief Accounting Officer true Common Stock 2026-02-02 4 S false 36142.00 1.39 D 312772.00 D Common Stock 2026-02-02 4 S false 13382.00 1.39 D 299390.00 D This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2025. This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2024. This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2025. /s/ Carolyn M. Rucci, attorney-in-fact for Richard C. Malabre 2026-02-04